8:30 a.m.
Welcome / Safe Harbor
Brian Moore, Investor Relations
Vision 2026: Achieving STAAR’s Global Growth Opportunity
Tom Frinzi, Chair of the Board and CEO
Extending EVO ICL’s Leadership Position
Magda Michna, PhD
Chief Clinical, Regulatory and Medical Affairs Officer
China: Durable Growth in the Largest Refractive Market Globally
Zheng Wang, MD
Chief Medical Officer, Refractive Surgery, Aier Eye Hospital Group (China)
9:20 a.m.
Q&A Session 1
9:30 a.m.
BREAK
9:45 a.m.
U.S. Refractive Market: From LASIK to Lens-Based
Stephen Slade, MD (United States)
Establishing EVO ICL as The First Choice for Doctors and Patients
Warren Foust, Chief Operating Officer
Surgeon Panel: The Global EVO ICL Experience
Scott Barnes, MD, Chief Medical Officer (Moderator)
Frank Kerkoff, MD (Netherlands)
Stephen Slade, MD (United States)
Blake Williamson, MD (United States)
Zheng Wang, MD (China)
Roger Zaldivar, MD (Argentina)
10:50 a.m.
BREAK
11:05 a.m.
Long Term Plan and Value Creation
Patrick Williams, Chief Financial Officer
Closing Remarks
Tom Frinzi, Chair of the Board and CEO
11:20 a.m.
Q&A Session 2
11:50 a.m.
Investor Day Concludes